These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

895 related articles for article (PubMed ID: 33974014)

  • 1. Diagnosis and Management of Headache: A Review.
    Robbins MS
    JAMA; 2021 May; 325(18):1874-1885. PubMed ID: 33974014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Treatments for Episodic Migraine in Adults: A Systematic Review and Meta-analysis.
    VanderPluym JH; Halker Singh RB; Urtecho M; Morrow AS; Nayfeh T; Torres Roldan VD; Farah MH; Hasan B; Saadi S; Shah S; Abd-Rabu R; Daraz L; Prokop LJ; Murad MH; Wang Z
    JAMA; 2021 Jun; 325(23):2357-2369. PubMed ID: 34128998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Migraine and Tension-Type Headache.
    Kahriman A; Zhu S
    Semin Neurol; 2018 Dec; 38(6):608-618. PubMed ID: 30522135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel synthetic treatment options for migraine.
    Negro A; Martelletti P
    Expert Opin Pharmacother; 2021 May; 22(7):907-922. PubMed ID: 33369482
    [No Abstract]   [Full Text] [Related]  

  • 5. Migraine and Tension-Type Headache: Diagnosis and Treatment.
    Burch R
    Med Clin North Am; 2019 Mar; 103(2):215-233. PubMed ID: 30704678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of New Pharmacologic Agents With Triptans for Treatment of Migraine: A Systematic Review and Meta-analysis.
    Yang CP; Liang CS; Chang CM; Yang CC; Shih PH; Yau YC; Tang KT; Wang SJ
    JAMA Netw Open; 2021 Oct; 4(10):e2128544. PubMed ID: 34633423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unmet Needs in the Acute Treatment of Migraine.
    Bentivegna E; Galastri S; Onan D; Martelletti P
    Adv Ther; 2024 Jan; 41(1):1-13. PubMed ID: 37943442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic novelties in migraine: new drugs, new hope?
    Do TP; Guo S; Ashina M
    J Headache Pain; 2019 Apr; 20(1):37. PubMed ID: 30995909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drugs for Migraine.
    Med Lett Drugs Ther; 2020 Oct; 62(1608):153-160. PubMed ID: 33434187
    [No Abstract]   [Full Text] [Related]  

  • 10. Headache: insight, understanding, treatment and patient management.
    Diener HC
    Int J Clin Pract Suppl; 2013 Jan; (178):33-6. PubMed ID: 23163546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting CGRP and 5-HT
    Moreno-Ajona D; Chan C; Villar-Martínez MD; Goadsby PJ
    Headache; 2019 Jul; 59 Suppl 2():3-19. PubMed ID: 31291016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Migraine.
    Ferrari MD; Goadsby PJ; Burstein R; Kurth T; Ayata C; Charles A; Ashina M; van den Maagdenberg AMJM; Dodick DW
    Nat Rev Dis Primers; 2022 Jan; 8(1):2. PubMed ID: 35027572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of new acute treatments for migraine.
    Lupi C; Benemei S; Guerzoni S; Pellesi L; Negro A
    Expert Opin Drug Metab Toxicol; 2019 Mar; 15(3):189-198. PubMed ID: 30714429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2022 Taiwan Guidelines for Acute Treatment of Migraine.
    Lau CI; Wang YF;
    Acta Neurol Taiwan; 2022 Jun; 31(2)():89-113. PubMed ID: 36153693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Therapies in Acute Migraine Management: Small-Molecule Calcitonin Gene-Receptor Antagonists and Serotonin 1F Receptor Agonist.
    Joyner KR; Morgan KW
    Ann Pharmacother; 2021 Jun; 55(6):745-759. PubMed ID: 32993366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the 5-HT
    Huang PC; Yang FC; Chang CM; Yang CP
    Prog Brain Res; 2020; 255():99-121. PubMed ID: 33008517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gepants for the treatment of migraine.
    Negro A; Martelletti P
    Expert Opin Investig Drugs; 2019 Jun; 28(6):555-567. PubMed ID: 31081399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the migraine treatment landscape prior to the introduction of calcitonin gene-related peptide inhibitors: Results from the Assessment of TolerabiliTy and Effectiveness in MigrAINe Patients using Preventive Treatment (ATTAIN) study.
    Kawata AK; Shah N; Poon JL; Shaffer S; Sapra S; Wilcox TK; Shah S; Tepper SJ; Dodick DW; Lipton RB
    Headache; 2021 Mar; 61(3):438-454. PubMed ID: 33594686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New therapeutic era for migraine attacks with recently approved monoclonal antibodies, ditans and gepants].
    Mínguez-Olaondo A; López-Bravo A; Quintas S; Nieves-Castellanos C; Layos-Romero A; Belvís R; Irimia P; Díaz-Insa S
    Rev Neurol; 2024 Jan; 78(2):47-57. PubMed ID: 38223948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Place of next generation acute migraine specific treatments among triptans, non-responders and contraindications to triptans and possible combination therapies.
    de Boer I; Verhagen IE; Souza MNP; Ashina M
    Cephalalgia; 2023 Feb; 43(2):3331024221143773. PubMed ID: 36739516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 45.